Literature DB >> 35300473

Autoimmune hepatitis and acquired partial lipodystrophy.

Christopher Bakewell1, Kavinda Dayasiri2, Rachel M Brown3, Astor Rodrigues1, Rachel Williams4, Geetha Anand2, Girish L Gupte5.   

Abstract

The lipodystrophies are an extremely rare group of metabolic conditions which are categorised based on their pathogenesis and phenotype. While primarily known for the striking loss of subcutaneous adipose tissue which they induce, they may also be associated with significant liver injury. In most cases, this results from the secondary deposition of lipid within hepatic parenchyma and is seen predominantly in generalised lipodystrophy. More rarely, patients may develop autoimmune hepatitis. We report a rare case of a 17-month-old boy who developed features of acquired partial lipodystrophy in association with anti-LKM1-positive autoimmune hepatitis following initial presentation with a Henoch-Schönlein purpura-like illness. We describe his challenging path to diagnosis and discuss his ongoing management in an effort to further our understanding of this rare but significant association. This report highlights the need for close clinical observation and a high index of suspicion for recognising early features of lipodystrophy. © Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  autoimmune liver disease; lipid metabolism; lipids; liver antibodies; paediatric liver disease

Year:  2021        PMID: 35300473      PMCID: PMC8862442          DOI: 10.1136/flgastro-2021-101824

Source DB:  PubMed          Journal:  Frontline Gastroenterol        ISSN: 2041-4137


  5 in total

Review 1.  THE SYNDROMES OF TOTAL LIPODYSTROPHY AND OF PARTIAL LIPODYSTROPHY.

Authors:  B SENIOR; S S GELLIS
Journal:  Pediatrics       Date:  1964-04       Impact factor: 7.124

2.  Progressive Generalized Lipodystrophy as a Manifestation of Autoimmune Polyglandular Syndrome Type 1.

Authors:  Ekaterina Sorkina; Elena Frolova; Dina Rusinova; Svetlana Polyakova; Elena Roslavtseva; Evgeny Vasilyev; Vasily Petrov; Anatoly Tiulpakov
Journal:  J Clin Endocrinol Metab       Date:  2016-02-18       Impact factor: 5.958

Review 3.  Clinical features and metabolic and autoimmune derangements in acquired partial lipodystrophy: report of 35 cases and review of the literature.

Authors:  Anoop Misra; Aparna Peethambaram; Abhimanyu Garg
Journal:  Medicine (Baltimore)       Date:  2004-01       Impact factor: 1.889

4.  Fatty Liver and Autoimmune Hepatitis: Two Forms of Liver Involvement in Lipodystrophies.

Authors:  Andreia Ribeiro; José Ricardo Brandão; Esmeralda Cleto; Manuela Santos; Teresa Borges; Ermelinda Santos Silva
Journal:  GE Port J Gastroenterol       Date:  2019-01-30

5.  Estimating the prevalence of generalized and partial lipodystrophy: findings and challenges.

Authors:  Elaine Chiquette; Elif A Oral; Abhimanyu Garg; David Araújo-Vilar; Praveen Dhankhar
Journal:  Diabetes Metab Syndr Obes       Date:  2017-09-13       Impact factor: 3.168

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.